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1. Introduction 
Pancreatic plasma membranes have an adenylate 
cyclase system responsive to pancreozymin and 
secretin [1-3 ] . Both hormones activate a common 
catalytic subunit via distinct receptors [1,2,4] which 
are not permanently coupled with the catalytic 
subunit [5]. Guanyl nucleotides act synergistically 
with these hormones [6]. 
In numerous eukaryotic systems, Gpp(NH)p and 
GTPyS are better activators than GTP and allow a 
quasi-irreversible activation of adenylate cyclase 
following binding to regulatory guanyl nucleotide 
site(s) 16-91; a finding which raises the question of 
the role of GTP hydrolysis in the adenylate cyclase 
system. The catecholamine-stimulated adenylate 
cyclase of turkey erythrocyte membranes has been 
shown to be associated with a catecholamine-stim- 
ulated GTPase (EC 3.6.1.-) [ 10,111. This GTPase 
is inhibited when adenylate cyclase is activated by 
isoproterenol and GTP-yS [ 121 or by cholera toxin 
[ 13 ,I 41. Based upon these observations a model has 
been proposed [15,161 in which adenylate cyclase 
oscillates between the active and inactive state and is 
regulated by the hydrolys~ of GTP. GTP binds to the 
inactive adenylate cyclase system, this complex is 
Abbreviations: Gpp(NH)p,guanosine S’-(p,~-imido)triphos- 
phate; GTP$S, guanosine 5’0(34hiotriphosphate); App(NH)p, 
adenosine S-(&T-imido)triphosphate; cyclic GMP, guanosine 
3’:5’-monophosphate; Pi, inorganic phosphate; NTPase, non- 
specific nucleoside triphosphatase; EGTA, ethylene glycol-bis- 
(2aminoethylether) Nfl,IV’fl’-tetraacetic acid; OCPZ, 
C-terminal octapeptide of pancreozymin; Boc, t-butyl-oxy- 
carbonyl; VIP, vasoactive intestinal peptide; D,,, concentra- 
tion required to exert half-maximal response (hormone 
binding, activation) 
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activated by the hormone and is subsequently 
deactivated by hydrolysis of GTP by the GTPase. 
After the detachment of GDP + Pi the system can 
again bind GTP. 
Indirect evidence for the existence of a GTPase 
as a regulatory component of the adenylate cyclase 
system has also been presented for hepatocytes [ 171 
and neuroblastoma cells [ 181. The present work on 
rat pancreatic plasma membranes illustrates adose- 
related activation of a specific GTPase by the pan- 
creozymin family of peptides and by secretin. The 
possible relevance of this GTPase activity to the 
regulation of adenylate cydase is discussed. 
2. Materials and methods 
2.1, Peptides and reagents 
The peptides of the pancreozymin family were 
obtained from sources detailed in [ 191, Synthetic 
secretin was a gift from Dr W. Koenig (Hoechst 
Pharma, Frankfurt). Trasylol was a gift from Bayer- 
Pharma (Brussels), Bacitracin, creatine phosphate, 
creatine phospho~~e ,Ap~~p and AT? were 
purchased from Sigma (St Louis, MO) and carbamyl- 
choline from-Federa (Brussels). GTP was obtained 
from Boehringer (Mannheim). [Y-~*P]GTP 
(15-20 Ci/mmol) and [CX-32P]ATP(0.5-3.0 Ci/mmol) 
were purchased from the Radiochemical Centre 
(Amersham). All other reagents were of analytical 
grade. 
22. Rat pancreatic plasma membranes 
These were prepared as in [2] and stored in liquid 
nitrogen until use. 
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2.3. GTPase assay 
The method in [ 1 l] was used with slight modifica- 
tion. Membrane proteins (5-10 pg) were incubated 
for 6 min at 37’C in 0.1 ml medium containing 
50 mM imidazole-HCl (pH 6.7 or 7.4), 0.3 mg/ml 
bacitracin, 500 UIK/ml trasylol, 5 mM MgClz, 0.1 mM 
EGTA, 0.1 mM ATP, 2 mM creatine phosphate, 3 U 
creatine phosphokinase, 2 mM &mercaptoethanol, 
0.5 mM App(NH)p, and 0.25 PM or 30 FM [y-32P]GTP 
(1-2 X 10’ cpm/assay). The reaction was initiated 
by the addition of membranes and stopped by adding 
0.1 ml of 2.5% sodium dodecylsulfate. The Pi liberated 
was isolated by chromatography on Celite-Norite [ 1 l] 
and the radioactivity was determined by liquid 
scintillation counting, For blank evaluation, the mem- 
branes were added after the incubation was stopped 
with sodium dodecylsulfate. All assays were performed 
in triplicate. 
2.4. Adenylate cyclase assay 
The hormone responsiveness of adenylate cyclase 
was tested as in [6] or in the medium detailed for 
GTPase assay (see above) except that 0.25 yM GTP 
and 1 mM cyclic AMP were added, and that 
[Q-~~P] ATP (3 X lo6 cpm/assay) was used in place of 
[y-32P]GTP. The membranes were incubated for 
6 min at 37°C @H 7.4) and radioactive cyclic AMP 
was separated and determined according to [20]. 
2.5. Protein determination 
This was by the Lowry method of [21]. 
3. Results 
Orientation experiments following the method 
in [ 1 l] allowed the detection of a specific GTPase in 
rat pancreatic plasma membranes. The hydrolysis of 
GTP at 0.25 PM (fig.1, curve A) was observed in the 
presence of 0.5 mM App(NH)p (to inhibit nonspecific 
NTPase(s)) and of an ATP-regenerating system (to 
suppress the transfer of y-32P from GTP to ADP). 
An isotope dilution curve of GTP hydrolysis (fig.2) 
indicated the presence of two enzymatic activities: 
one with high affinity for GTP (app Km 0.1-0.2 PM, 
data not shown); a second with a lower affinity (app 
Km > 30 PM). Pancreatic plasma membrane prepara- 
tions have a NTPase activity (app Km 80 PM for 
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Fig.1. Time course of GTP hydrolysis at pH 6.7 in the presence 
of 0.25 PM GTP (curve A, e---e) or 30 MM GTP (curve B, 
o-o); basal specific GTPase (A---a) was defined as A 
minus B. Results are representative of 4 experiments. 
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Fig.2. Isotope dilution curve of GTP hydrolysis. Unlabeled 
GTP was added to a fixed quantity of [7-32P]GTP to give the 
final concentration indicated in the abscissa. Pancreatic 
plasma membranes were incubated for 6 min at pH 6.7. The 
dotted lines indicate the % of GTP hydrolyzed in the presence 
of 0.25 PM GTP (A) and 30 PM GTP (B). Results are repre- 
sentative of 4 experiments. 
Volume 99, number 2 FEBS LETTERS March 1979 
Mg-GTP) which could account for the activity at 
30 PM GTP 1221. The contribution of the residual 
NTPase activity to hydrolysis of GTP at 0.25 E.IM was 
estimated by subtracting the proportion of GTP 
hydrolyzed at 30 PM since the increase in GTP from 
0.25-30 FM must cause a relatively proportional 
increase in NTPase activity, considering the app Km 
value of this activity with Mg-GTP [22]. The mean 
activity of nonspecific NTPase was 110 pmol GTP/ 
min.mg protein at pH 7.4 and 70 pmol GTP/minmg 
protein at pH 6.7 whereas the basal specific GTPase 
was 25 pmol GTP~rninmg protein at both pH values. 
The basal specific GTPase represented 18-30% of the 
total activity measured with 0.25 PM GTP depending 
on the membrane batch utilized. 
In routine assays, the reaction time was futed at 
6 min so that GTP hydrolysis was > 20% at either 
pH 7.4 or 6.7. Under these conditions, the reaction 
rate was proportional to the amount of membranes 
added in the lo-60 pg protein range. Addition of 
1 PM OC-PZ caused a 2-fold increase in specific 
GTPase activity at pH 6.7 whereas nonspecific residual 
NTPase activity was unaffected (fig.3). Secretin did 
not, however, provoke a stimulation of specific GTPase 
activity at pH 6.7. 
As adenylate cyclase activity is poorly s~ulated 
by secretin at pH 6.7, hormone stimulations of GTPase 
Fig.3. Effect of 1 /AM OC-PZ on GTP hydrolysis. Pancreatic 
plasma membranes were incubated at pH 6.7 with 0.26 MM 
[$*P]GTP in the presence (a and A) or absence (o and A) 
of 1 /AM OC-PZ. GTP was 0.25 PM (* and o) or 30 crM 
(A and A). Mean of 2 experiments performed in triplicate. 
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FigA. Dose-effect re~tion~ip of hormones and hormone 
analogs on the specific GTPase activity. Pancreatic plasma 
membranes were incubated for 6 min at pH 7.4 with 0.25 nM 
or 30 #M GTP. Each increment over specific basal value is 
the mean of 2-5 separate xperiments (vertical bars indicate 
SEM values in the latter case). Legend (from left to right): 
(o-0) OC-PZ; (+ - - - +) Boc (4-10)~[Nle*]-caerulein; (A-A) 
caerulein; (o- 0) secretin; (e-m) VIP; (A-A) pentagastrm; 
[o-o) Tyr(SO,H)-(l-lO)-caerulein; (*) carbamylcholme. 
were reexamined at pH 7.4. pH 7.4 was indeed optimal 
for adenylate, cyclase activation with GTP used in 
comb~ation with either OC-PZ or secretin; adenylate 
cyclase activity measured at pH 7.4 in the medium 
used for GTPase assays, i.e., in the presence of 
0.25 ,uM GTP, was activated 3.6-fold with 0.1 I.IM 
secretin and 5.8.fold with 0.1 E.IM OC-PZ (data not 
shown). 
Dose-response curves for GTPase stimulation with 
hormones and hormone analogs at pH 7.4 are shown 
in fig.4. OC-PZ was the most potent activator: a 
stimulation occurred at 0.1 nM. Boc(4-lO)-(Nles)- 
caerulein and caerulein, two full agonists of OC-PZ 
vis-&vis adenylate cyclase 1193, produced the same 
maximal effect on GTPase activity but their potency 
was -IO-times lower. Pentagastrin, a weak and partial 
agonist of OC-PZ on pancreatic adenylate cyclase 
[ 191, produced a 30% increase in specific GTPase 
activity at the highest concentration tested (33 PM). 
Tyr (SOsH)-(7-lO)caerulein, which is even less 
efficient than pentagastrin on adenylate cyclase 
[ 191, did not produce any significant increase in 
GTPase activity at 0.1 mM. 
Secretin was found to be a weak activator of 
GTPase: a 33% s~ulation was observed at 1 uM. 
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VIP at < 6 E.~M did not significantly activate the 
specific GTPase. Carbamylcholine which does not 
activate pancreatic adenylate cyclase [23], was also 
without effect on GTPase activity even when used 
at 0.1 mM. 
4. Discussion 
The high activity of NTPase(s) has made it difficult 
to demonstrate a hormone-stimulated GTPase activity 
in pancreatic plasma membranes. Despite the presence 
of this high residual nonspecific activity, an 80% 
increase in specific GTPase activity could be observed 
with OC-PZ. Basal and specific GTPase activities, on a 
mg protein basis, were 5fold higher in rat pancreatic 
plasma membranes than in turkey erythrocyte mem- 
branes [121 while maximal adenylate cyclase activity 
(800 pmol/min .mg protein) in the same pancreatic 
plasma membranes stimulated according to [6] with 
1 PM OC-PZ plus 50 FM Gpp(NH)p was twice that 
reported for turkey erythrocyte membranes activated 
with isoproterenol and Gpp(NH)p [ 121. 
Three indirect pieces of evidence suggest that the 
GTPase activity was coupled with adenylate cyclase 
activation and OC-PZ receptors. 
(1) 
(2) 
(3) 
Dose-effect curves of adenylate cyclase activa- 
tion and GTPase stimulation by OC-PZ and 
related peptides indicated similar elative affinities 
[19,23]. 
The 5 X 1O-1o M concentration of OC-PZ which 
activated half-maximally (DSo) the specific 
GTPase (fig A) was lower than the DSo for adenyl- 
ate cyclase activation in the presence of GTP and 
Gpp(NH)p (3 X 10” M and 1 X lo* M, respec- 
tively [6] ). 
The app Km for GTP of the specific GTPase, the 
DSo of GTP which activates adenylate cyclase in 
the presence of OC-PZ and the Dso of GTP and 
Gpp(NH)p inhibiting _[8-3H] Gpp(NH)p binding 
to high affinity binding sites are similar, i.e., 
l-2 X lo-’ M (fig.2 and [6]). 
With secretln, lesser stimulation of specific GTPase 
was observed than that with OC-PZ. The secretin 
activation of adenylate cyclase is, however, not 
maximal at low concentrations of GTP (see results 
and iig3A in [6]): at 0.25 PM GTP, the concentration 
required for the assay of the specific GTPase, an 
optimal concentration of secretin produces only half 
the effect of OC-PZ. 
Acknowledgements 
This work was supported by grant RO-IAM- 
from the National Institutes of Health (USA) and by 
grant no. 20,403 from the Belgian Medical Scientific 
Research Fund. The authors wish to thank J. Camus 
for preparing pancreatic plasma membranes. 
References 
[l] Kempen, H. J. M., De Pont, J. J. H. H. M. and Bonting, 
S. L. (1974) Biochim. Biophys. Acta 370,573-584. 
[2] Svoboda, M., Robberecht, P., Camus, J., Deschodt- 
Lanckman, M. and Christophe, J. (1976) Eur. J. 
Biochem. 69,185-193. 
(31 Milutinovic, S., Schulz, I. and Rosselin, G. (1976) 
Biochim. Biophys. Acta 436,113-127. 
[4] Christophe, J. P., Conlon, T. P. and Gardner, J. D. 
(1976) J. Biol. Chem. 251,4629-4634. 
[S] Svoboda, M., Robberecht, P. and Christophe, J. (1978) 
FEBS Lett. 92,351-356. 
[6] Svoboda, M., Robberecht, P., Camus, J., Deschodt- 
[71 
PI 
PI 
[lOI 
[Ill 
[I21 
Lanckman, M. and Christophe, J. (1978) Eur. 
J. Biochem. 83,287-297. 
Londos, C., Salomon, Y., Lin, M. C., Harwood, J. P., 
Schramm,M., Wolff, J. and RodbeII, M. (1974) Proc. 
Natl. Acad. Sci. USA 71,3087-3090. 
Pfeuffer, T. and Helmreich, E. J:M. (1975) J. Biol. 
Chem. 250,867-876. 
Lefkowitz, R. J. and Caron, M. G. (1975) J. Biol. 
Chem. 250,4418-4422. 
Cassel, D. and Sehnger, Z. (1977) J. Cycl. Nucl. Res. 
3,11-22. 
Cassel, D. and Sehnger, Z. (1976) Biochim. Biophys. 
Acta 452,538-551. 
Cassel, D. and Sehnger, Z. (1977) Biochem. Biophys. 
Res. Commun. 77,868-873. 
Cassel, D. and Sehnger, Z. (1977) Proc. Natl. Acad. ]131 
Sci. USA 74,3307-3311. 
[ 141 Cassel, D. and Pfeuffer, T. (1978) Proc. Natl. Acad. 
Sci. USA 75,2669-2673. 
[15] Levitzki, A. (1977) Biochem. Biophys. Res. Commun. 
74,1154-1159. 
[16] Cassel,D.,Levkovitz,H.and SeIinger, Z. (1977) J. Cycl. 
Nucl. Res. 3,393-406. 
[ 171 RendelI, M. S., Rodbell, M. and Berman, M. (1977) 
J. Biol. Chem. 252,7909-7912. 
[18] Lewlnson, S. L. and Blume, A. J. (1977) J. Biol. Chem. 
252.3766-3774. 
Volume 99, number 2 FEBS LE’lTERS March 1979 
[ 191 Robberecht, P., Deschodt-Lanckman, M., Morgat, J. L. 
and Christophe, J. (1978) Eur. J. Biochem. 91,39-48. 
[20] Salomon, Y ., Londos, C. and Rodbell, M. (1974) Anal. 
Biochem. 58,541-548. 
[21] Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and 
Randall, R. J. (1951) J. Biol. Chem. 193,265-275. 
[22] Lambert, M. and Christophe, J. (1979) Eur. J. Biochem. 
in press. 
[23] Christophe, J., Robberecht, P. and Deschodt- 
Lanckmann, M. (1977) in: Progress in Gastroenterology 
(Glass, G. B. J. ed) vol. 3, pp. 241-284, Grune and 
Stratton, New York. 
307 
